CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Comparison of myo-inositol and metformin on glycemic control, lipid profiles and gene expression related to insulin and lipid metabolism in PCOS women: arandomized controlled clinical trial

Credit to Download: 0 | Page Numbers 2 | Abstract Views: 45
Year: 2019
COI code: DTOGIMED03_061
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Comparison of myo-inositol and metformin on glycemic control, lipid profiles and gene expression related to insulin and lipid metabolism in PCOS women: arandomized controlled clinical trial

  Fatemeh Foroozanfard - Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan,I.R. Iran
  Zatollah Asemi - Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences,Kashan, I.R. Iran
  Esmat Aghadavod - Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences,Kashan, I.R. Iran

Abstract:

Background and Aim : This investigation was conducted to evaluate comparison of myo-inositol andmetformin on glycemic control, lipid profiles and gene expression related to insulin and lipid metabolismin women with polycystic ovary syndrome (PCOS).Methods : This randomized controlled trial was conducted on 53 women with PCOS, aged 18-40 yearsold. Subjects were randomly allocated into two groups to take either myo-inositol (n=26) or metformin(n=27) for 12 weeks. Glycemic control and lipid profiles were determined at baseline and after the 12-weekintervention. Gene expression related to insulin and lipid metabolism was done on peripheral bloodmononuclear cells (PBMCs) of PCOS women using RT-PCR method.Results : Myo-inositol supplementation, compared with metformin, significantly reduced fasting plasmaglucose ( -5.12 mg/dL; 95% CI, -8.09, -2.16; P=0.001), serum insulin levels ( -1.49 μIU/mL; 95% CI, -2.28, -0.70; P<0.001), homeostasis model of assessment-insulin resistance ( -0.36; 95% CI, -0.55, -0.17;P<0.001), serum triglycerides ( 12.42 mg/dL; 95% CI, -20.47, -4.37; P=0.003) and VLDL-cholesterollevels ( -2.48 mg/dL; 95% CI, -4.09, -0.87; P=0.003), and significantly increased the quantitative insulinsensitivity check index ( 0.006; 95% CI, 0.002, 0.01; P=0.006) compared with metformin. Moreover, myoinositolsupplementation upregulated gene expression of peroxisome proliferator-activated receptor gamma(PPAR- ) (P=0.002) compared with metformin.Conclusion : Overall, taking myo-inositol, compared with metformin, for 12 weeks by women with PCOShad beneficial effects on glycemic control, triglycerides and VLDL-cholesterol levels, and gene expressionof PPAR-γ.

Keywords:

Myo-inositol, metformin, glycemic control, lipid profiles, polycystic ovary syndrome

Perma Link

https://www.civilica.com/Paper-DTOGIMED03-DTOGIMED03_061.html
COI code: DTOGIMED03_061

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Foroozanfard, Fatemeh; Zatollah Asemi & Esmat Aghadavod, 2019, Comparison of myo-inositol and metformin on glycemic control, lipid profiles and gene expression related to insulin and lipid metabolism in PCOS women: arandomized controlled clinical trial, 3rd debatable topics on obstetrics gynecology & infertility, تهران, دانشگاه علوم پزشكي و خدمات بهداشتي و درماني شهيد بهشتي, https://www.civilica.com/Paper-DTOGIMED03-DTOGIMED03_061.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Foroozanfard, Fatemeh; Zatollah Asemi & Esmat Aghadavod, 2019)
Second and more: (Foroozanfard; Asemi & Aghadavod, 2019)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 1146
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.